Abstract

To evaluate the effects of the discontinuation of antithrombotic drugs on intraocular pressure (IOP) reduction and complications from ab interno trabeculotomy for patients with glaucoma. We performed a retrospective chart review on the data of patients treated with antithrombotic agents who have undergone ab interno trabeculotomy through Tanito microhook combined with cataract surgery at the Asahi General Hospital and the Tokyo University Hospital, with 6 months of follow-up. The patients were classified into two groups depending on whether they discontinued (AT-) or continued (AT+) antithrombotic therapy during the perioperative phase. The demographics, pre- and postoperative IOP, medication score, best-corrected visual acuity (BCVA), and postoperative complications were analyzed preoperatively and postoperatively at 1 week and 1–6 months. The series included 44 eyes from 44 Japanese patients. The AT- and AT+ groups included 21 eyes from 21 patients and 23 eyes from 23 patients, respectively. The decrease in IOP from the baseline at 1 week postoperative was significantly different between the two groups (p = 0.009), but there were no significant differences observed in the other visits. Hyphema and IOP spikes exceeding 30 mmHg occurred in 10% and 10% of AT- participants, and in 43% and 26% of AT+ participants, respectively. Hyphema and spikes with hyphema occurred more frequently in the AT+ than in the AT- group (p = 0.02 and p = 0.05). The number of patients who had spikes was not significantly different (p = 0.27). In trabeculotomy using the Tanito microhook®, discontinuing antithrombotic therapy had better IOP-lowering effects and less postoperative complications.

Highlights

  • Trabeculotomy aims to cleave the trabecular meshwork (TM) and the inner wall of the Schlemm’s canal (SC), which is the main site of resistance for aqueous outflow [1,2,3,4,5,6,7]

  • minimally invasive glaucoma surgery (MIGS) is emerging as a standard concept in the field [8]

  • We evaluated the effects of antithrombotic therapy during the perioperative phase

Read more

Summary

Introduction

Trabeculotomy aims to cleave the trabecular meshwork (TM) and the inner wall of the Schlemm’s canal (SC), which is the main site of resistance for aqueous outflow [1,2,3,4,5,6,7]. With the recent developments in new devices or implants, minimally invasive glaucoma surgery (MIGS) is emerging as a standard concept instead of ab externo trabeculotomy [8]. Devices or implants for MIGS are minimally invasive and require high biocompatibility. Their safety and the fast recovery of patients in terms of visual acuity (VA) and quality of life (QOL) have been fully evaluated in outflow channel surgeries [1,2,3, 7,8,9,10,11,12,13,14,15,16,17]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call